Glycemic Variability of Combination Therapies in T2DM
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 178 participants.
Also called NCT07442006
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 178 participants
- Sponsor
- Registry
-
NCT07442006
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT07442006. Randomized; no masking; primary purpose treatment. Start 2025-10-29 (actual); primary completion 2027-03-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Glycemic Variability of Combination Therapies in T2DM
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Drug)
- Empagliflozin/Metformin
- Intervention (Drug)
- Anagliptin
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Empagliflozin/Linagliptin
- Lead sponsor
- JW Pharmaceutical
Record details
- Record id
cardio:ct-nct07442006- Content hash
43a5600a6814ebff8c2798615befc3d071877c770cb78f340b7350ab4cccefa0